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Abstract
Background Children with cerebral palsy (CP) often walk
with a slower speed and a higher energy cost. Their
walking performance and choice of mobility method may
vary in different environments. Independent mobility is
important for activity and participation.
Questions/purposes We described walking performance
at different distances and environments in relation to gross
motor function, CP subtype, and age.
Patients and Methods We performed a cross-sectional
study including all 562 children 3 to 18 years with CP
living in southern Sweden during 2008. Data were
extracted from a Swedish CP register and healthcare pro-
gram. The Functional Mobility Scale (FMS) was used for
rating mobility at home (5 m), at school (50 m), and in the
community (500 m). The FMS scores were analyzed in
relation to Gross Motor Function Classiﬁcation System
(GMFCS) level, CP subtype, and age.
Results In this population, 57% to 63% walked 5 to
500 m without walking aids and 4% to 8% used walking
aids. We found a correlation between FMS and GMFCS.
The walking performance varied between the subtypes
from 96% to 98% in those with spastic unilateral CP to
16% to 24% in children with dyskinetic CP. An increased
proportion of children walked independently on all sur-
faces in each successive age group.
Conclusions The overall walking performance increased
up to 7 years of age, but the proportion of children walking
independently on uneven surfaces was incrementally
higher in each age group up to 18 years. The ability to walk
on uneven surfaces is important for achieving independent
walking in the community.
Introduction
Cerebral palsy (CP) is the most common cause of motor
disability in childhood [1, 10, 30, 36]. The diagnosis
includes children with a wide range of mobility from
independent walking to assisted (dependent) wheeled
mobility.
Normal walking is extremely efﬁcient and advances the
body safely from place to place with a minimum of energy
[8]. Children with CP often start to walk later than non-
disabled children [20] and they walk with a slower speed
and higher energy cost [7]. There is a strong correlation
between the energy cost of walking and the degree of
motor impairment [19, 31]. There is also increased
energy consumption when walking with assistive devices
[6, 21, 32, 38]. Many children with CP walk in a crouched
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over time as a result of increasing muscle contractures,
increasing body weight, and decreasing muscle strength
[22]. Thus, the achieved walking ability is not always
maintained through adolescence and adulthood [4, 18, 35].
Independent mobility is important for activity, partici-
pation, and self-sufﬁciency, reducing the dependence on
caregivers and the environment [5, 26, 28, 29, 37]. Safety
and efﬁciency are important factors when choosing
mobility methods for different environments [28]. Envi-
ronmental and personal factors inﬂuence the performance,
what a child actually does do in a daily life situation [16,
42]. Older children and adolescents with CP are more
active outside the home with friends than younger children
[26] and the ability to walk on uneven surfaces is important
to achieve independent mobility and improve accessibility
in the community, where different surfaces, inclines, curbs,
and stairs are more common [28]. Knowledge of the
walking performance in a total population of children with
CP is of importance for healthcare planning as well as for
prediction of future performance in a young child with CP.
We presume the walking performance in children with CP
depends on the child’s gross motor function, CP subtype,
and age and varies at different distances and environments.
Our purposes were (1) to describe the most frequent
mobility method for different distances and environments
in a total population of children with CP; (2) to examine
the association between walking performance and level of
gross motor function, CP subtype; and (3) to describe the
walking performance in different age groups.
Patients and Methods
We performed a cross-sectional study in a total population
of children with CP living in southern Sweden during 2008,
in total 562 children aged 3 to 18 years (mean age,
10.9 years). There is a healthcare program for children
with CP in Sweden (CPUP) [11, 12]. The associated reg-
ister includes all children with CP born after January 1,
1990, living in the counties of Ska ˚ne and Blekinge, which
have a total population of approximately 1.3 million. The
number of children with CP in the area corresponds to a
prevalence of 2.4 per 1000 live births [23, 39]. A search is
made regularly to ﬁnd all children with CP in the area and
invite them to participate in CPUP, and almost all families
(98%) have agreed to participate [39]. Data from the CPUP
register were used to analyze the most frequent mobility
method in different environments in a total population of
children with CP. The study was approved by the Medical
Research Ethics Committee at Lund University.
The CPUP healthcare program includes a continuing
standardized followup of motor function, clinical ﬁndings,
and treatment. The child is examined annually by its local
physiotherapist. The recording form (at http://www.cpup.se)
includes the Functional Mobility Scale (FMS) [9]V e r s i o n2
with information on the child’s walking performance at
three speciﬁc distances: 5 m, 50 m, and 500 m represent-
ing the child’s mobility at home, at school, and in the
community, respectively (Table 1). The mobility is rated
according to the need of assistive devices and is assessed
by questions put to the child or parent and not by direct
observation. The FMS is reliable, valid, and sensitive [9]
with substantial agreement between direct observation and
parental report [14].
The FMS ratings were analyzed in relation to level of
gross motor function, CP subtype, and age. To analyze
data, the children were divided into different age groups
according to the Swedish school system: 3 to 6, 7 to 9, 10
to 12, 13 to 15, and 16 to 18 years (Table 2). The gross
motor function for each child was determined by the
child’s physiotherapist using the Gross Motor Function
Classiﬁcation System (GMFCS) [24, 27], a ﬁve-level
system for children and youth with CP based on self-
initiated movement, in which Level I describes the highest
level of function and Level V the lowest. The CP subtypes
were classiﬁed by the child’s neuropediatrician according
to Surveillance of Cerebral Palsy in Europe (SCPE) [36]
as spastic unilateral, spastic bilateral, dyskinetic, ataxic,
and unclassiﬁed or mixed CP. The classiﬁcation is pri-
marily based on neurologic signs as spastic, dyskinetic, and
ataxic. The spastic subtype is divided into unilateral
(hemiplegia) or bilateral (diplegia, tetraplegia) depending
on localization.
Kruskal-Wallis test showed no differences in distribu-
tion of GMFCS levels (p = 0.783) or classiﬁed CP
subtypes (p = 0.263) between the age groups (Table 2).
Table 1. The Functional Mobility Scale (FMS) Version 2
Questions
1. How does your child move around for short distances in the
house? (5 m)
2. How does your child move in and between classes at school?
(50 m)
3. How does your child move around for long distances such as at
the shopping center? (500 m)
Ratings
6. Independent on all surfaces
5. Independent on level surfaces
4. Uses sticks (one or two)
3. Uses crutches
2. Uses a walker or frame
1. Uses wheelchair
C. Crawling
N. Does not apply, eg, child does not complete the distance
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123Some children are not classiﬁed until 4 years of age so
when the unclassiﬁed subtype was included, Kruskal-
Wallis showed a difference in subtypes between the age
groups (p = 0.004) in which more children in the age
group 3–6 years were unclassiﬁed. FMS ratings were
available for all 562 children for 500 m but missing in two
children for 5 and 50 m (Table 3).
Spearman’s rank correlation (rs) was used to calculate
correlations between FMS distances and between FMS and
GMFCS levels. A linear by linear association test was used
for analyzing trends in FMS related to GMFCS level and to
age. The Kruskal-Wallis test was used to analyze differ-
ences related to CP subtype, and post hoc analyses were
performed using the Mann-Whitney test. Kruskal-Wallis
test was also used to analyze differences in the distribution
of GMFCS levels and CP subtypes between the age groups.
The relationship between independent walking and age was
estimated using binary logistic regression adjusted for CP
subtype. The analysis results in an odds ratio, which may
be described as a ratio between two odds that expresses the
probability for an event to occur. The results are presented
as odds ratios (ORs) with 95% conﬁdence interval and p
values. The FMS was used as the outcome. Age was used
as a categorical variable with 3 to 6 years as the reference
category. Independent walking on all surfaces (FMS 6) and
independent walking both on all surfaces and on level
surfaces (FMS 6-5) were compared with all other catego-
ries. Odds is the ratio of the probabilities of walking
without aids (FMS 6-5) compared with not walking without
aids (FMS 4-1,C,N) and walking independently on all
surfaces (FMS 6) compared with not walking on all sur-
faces (FMS 5-1,C,N) in different age groups. If the odds for
walking are identical in each group, the odds ratio is equal
to one. SPSS Version 17.0 (SPSS Inc, Chicago, IL) was
used for all statistical analyses.
Results
According to the FMS, 63% of the children walked without
aids (FMS 6 or 5) at home, 60% at school, and 57% in the
community setting (Table 3). Walking aids (FMS 4-2)
were used by 4% to 8% at the three distances and a
wheelchair (FMS 1) by 11% to 18%. Crawling at home
(FMS C) was reported for 7% of the children. For the
remaining children, the ratings were N: does not apply (the
child does not complete the distance) (Table 3). There
were high correlations between the individual FMS scores
at the three distances (Table 4).
Table 2. Details of the 562 children
Age (years) Number of children Gender GMFCS level CP subtype
Boys Girls I II III IV V SU SB DY AT UC
3–6 116 (20.6%) 67 49 51 9 21 16 19 25 27 21 7 36
7–9 104 (18.5%) 53 51 52 14 8 19 11 35 38 13 9 9
10–12 117 (20.8%) 67 50 51 22 14 17 13 38 47 17 5 10
13–15 117 (20.8%) 78 39 59 14 7 18 19 37 49 16 13 2
16–18 108 (19.2%) 61 47 51 17 14 14 12 28 48 16 14 2
Total 562 326 236 264 76 64 84 74 163 209 83 48 59
GMFCS = Gross Motor Function Classiﬁcation System; CP = cerebral palsy; SU = spastic unilateral; SB = spastic bilateral; DY = dyski-
netic; AT = ataxic; UC = unclassiﬁed or mixed type.
Table 3. Distribution of FMS scores at 5, 50, and 500 m
FMS Home 5 m School 50 m Community 500 m
6 245 (43.8%) 238 (42.5%) 228 (40.6%)
5 106 (18.9%) 97 (17.3%) 90 (16.0%)
4 8 (1.4%) 8 (1.4%) 7 (1.2%)
3 1 (0.2%) 0 (0%) 0 (0%)
2 26 (4.6%) 39 (7.0%) 15 (2.7%)
1 62 (11.1%) 71 (12.7%) 102 (18.1%)
C 39 (7.0%)
N 73 (13.0%) 107 (19.1%) 120 (21.4%)
Missing 2 (0.4%) 2 (0.4%) 0 (0%)
FMS = Functional Mobility Scale.
Table 4. Correlations between GMFCS levels and FMS at 5, 50, and
500 m
Scales GMFCS FMS 5 m FMS 50 m FMS 500 m
GMFCS 1.000 –0.907 –0.912 –0.911
FMS 5 m –0.907 1.000 0.972 0.948
FMS 50 m –0.912 0.972 1.000 0.969
FMS 500 m –0.911 0.948 0.969 1.000
All correlations are statistically signiﬁcant (p\0.001), Spearman’s
correlations; GMFCS = Gross Motor Function Classiﬁcation System;
FMS = Functional Mobility Scale.
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123There was a high correlation between FMS and GMFCS
for all FMS distances (Table 4). The FMS ratings were
lower (p\0.001) with increasing distance for all GMFCS
levels but most apparent for Level III followed by Levels II
and IV (Fig. 1). Most children at GMFCS Levels I and II
walked all distances independently but with more difﬁ-
culties on uneven surfaces and longer distances for those at
GMFCS II. Walking aids were most frequently used by
children at Level III, 33% at home and 52% at school,
whereas most of them used a wheelchair in the community.
At GMFCS Level IV, 10% to 11% used walking aids for
shorter distances, whereas most children used a wheelchair
for all three distances. A majority of the children at Level
V did not complete the distance (Fig. 1).
The FMS scores varied between the different subtypes
(p\0.001) and were lower with increasing distances, most
pronounced in children with ataxia (Fig. 2). Post hoc
analyses showed differences (p\0.001) between all sub-
types at all three distances except among the spastic
bilateral, ataxic, and unclassiﬁed subtypes. Almost all
children with spastic unilateral CP walked all three dis-
tances without aids (FMS 6-5). Walking performance
(FMS 6-2) was seen in 65% to 81% of children with ataxic
CP, 52% to 64% with bilateral spastic CP, and 16% to 24%
with the dyskinetic subtype. Unaided walking on uneven
surfaces (FMS 6) was equally common in ataxic and
spastic bilateral CP (30%) and least common in dyskinetic
CP (10%). Walking aids were most used by children with
Fig. 1 Functional mobility at 5,
50, and 500 m related to Gross
Motor Function Classiﬁcation
System (GMFCS) level. The
Functional Mobility Scale (FMS)
scores were lower (p\0.001)
with increasing distance for all
GMFCS levels.
Fig. 2 Functional mobility at 5,
50, and 500 m related to cerebral
palsy subtype. SU = spastic uni-
lateral; SB = spastic bilateral;
AT = ataxic; DY = dyskinetic;
UC = unclassiﬁedormixedtype.
The Functional Mobility Scale
(FMS) scores varied between the
different subtypes (p\0.001).
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123ataxic or spastic bilateral CP in the school environment
(Fig. 2).
The overall functional mobility increased (p = 0.011,
p = 0.034, p = 0.016) with age at all three distances
(Fig. 3). The walking performance without aids (FMS 6-5)
increased from preschool children 3 to 6 years (43%–51%)
up to 7 year olds (62%–65%) and then remained on that
level up to 18 year olds. The ORs for walking without aids
(FMS 6-5) was almost double in all age groups compared
with 3 to 6 year olds but was almost the same in 7 and
18 year olds (Table 5). However, an increased proportion
of children walked independently on all surfaces (FMS 6)
in each successive age group up to 18 years. Compared
with 3 to 6 year olds, the OR increased to 2.08 for 7 to
9 year olds and to 4.92 for 16 to 18 year olds at 500 m
(Table 5). This implies that an 18 year old has a larger
chance than a 7 year old of walking independently on all
surfaces at home, at school, and in the community.
Discussion
The walking performance in children with CP varies as a
result of personal and environmental factors. Knowledge of
the walking performance in a total population is important
for healthcare planning and for prediction of future per-
formance in a young child with CP. The FMS describes
walking performance at 5, 50, and 500 m, representing the
Fig. 3 Functional mobility at 5,
50, and 500 m related to age.
The Functional Mobility Scale
(FMS) scores increased (p =
0.011, p = 0.034, p = 0.016)
with age at all three distances.
Table 5. Binary logistic regression of independent walking in relation to age adjusted for cerebral palsy subtypes
Category Age OR 5 m (95% CI) p Value OR 50 m (95% CI) p Value OR 500 m (95% CI) p Value
FMS 6 3–6 reference
7–9 1.84 (0.94–3.57) 0.073 2.19 (1.12–4.29) 0.023 2.08 (1.05–4.10) 0.036
10–12 2.56 (1.34–4.89) 0.004 2.90 (1.51–5.59) 0.001 3.18 (1.64–6.17) \0.001
13–15 3.00 (1.54–5.85) 0.001 3.42 (1.74–6.74) \0.001 3.80 (1.91–7.53) \0.001
16–18 3.84 (1.94–7.60) \0.001 4.17 (2.08–8.33) \0.001 4.92 (2.45–9.88) \0.001
FMS 5-6 3–6 reference
7–9 1.53 (0.77–3.03) 0.227 2.01 (1.01–3.99) 0.047 2.17 (1.09–4.33) 0.028
10–12 1.82 (0.94–3.55) 0.078 1.81 (0.93–3.51) 0.081 2.05 (1.04–4.01) 0.038
13–15 1.53 (0.77–3.04) 0.225 1.86 (0.94–3.68) 0.077 2.34 (1.17–4.69) 0.016
16–18 1.83 (0.91–3.68) 0.089 1.87 (0.94–3.74) 0.076 2.55 (1.27–5.13) 0.009
Odds ratios (ORs) with 95% conﬁdence interval (CI) and p values for independent walking on all surfaces (FMS 6) and independent walking on
level surfaces (FMS 5) compared with all other categories; age was used as a categorical variable with 3 to 6 years as the reference category;
FMS = Functional Mobility Scale. If the odds for walking are identical in each group, the odds ratio is equal to one. The probability of walking
without aids is almost double in all age groups compared with 3 to 6 year olds but is almost the same from 7 to 18 year olds. The OR for walking
independently on all surfaces (FMS 6) is higher in each successive age group up to 18 years at all distances and environments.
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123child’s mobility at home, at school, and in the community,
respectively. Our purposes were to describe the most fre-
quent mobility method in a total population of children
with CP and to examine the association between walking
performance and GMFCS level, CP subtype, and age.
We note limitations to our study. First, the FMS ratings
provide only the child’s most frequently used mobility
method. Some children may use several methods such as
both walking with devices and using a wheelchair at
school. Second, this is a cross-sectional study showing the
difference between age groups at a speciﬁc moment, not
changes over time.
In an analysis from the SCPE database comprising
10,042 children with CP in Europe, Beckung et al. [2]
reported that in 5-year-old children, 54% had unaided
walking and 16% walked with aids. Rumeau-Rouquette
et al. [34] in a French study reported that in 8- to 14-year-
old children, 38% to 44% had unaided walking and 13% to
28% walked with aids. The number of children with
unaided walking in the present study is similar to Beckung
et al. but higher than Rumeau-Rouquette et al. In the pre-
vious studies, it is not clear at what distance or in which
environment the walking ability was recorded. The pro-
portion of children using walking aids was smaller in our
study. The use of walking aids was most common in
children at GMFCS Level III and in children with ataxic or
spastic bilateral CP in the school environment. Several
studies document increased energy consumption when
walking with assistive devices [6, 21, 32, 38]. Jahnsen et al.
[17] reported an increased experience of freedom, speed of
locomotion, and reduced energy cost in adults with CP at
GMFCS III when starting to use a wheelchair for mobility.
Safety and efﬁciency are important factors when choosing
mobility method for different environments [28]. This may
explain why wheelchairs were more frequently used than
walking aids and walkers were more frequently used than
crutches and sticks. A rather high accessibility for wheeled
mobility in the community and no charge for wheelchairs
may increase the use of wheelchairs instead of walking aids
in our study. The use of a wheelchair for those with limited
walking ability may preserve energy and prevent physical
fatigue and thereby maintain walking performance in
adolescents and adults.
The walking performance increased with GMFCS level.
A relationship between the FMS and the GMFCS would be
expected but has, to our knowledge, not previously been
examined. We found a high correlation between the two
instruments, indicating that GMFCS is a good predictor of
walking performance. FMS is constructed to measure
functional mobility in children corresponding to GMFCS
Levels I to IV. To discriminate assisted and independent
wheelchair mobility, a further level, between FMS 1 and N,
could be considered.
The number of children who walked independently
increased up to 7 years of age. This is in agreement with
the study by Bleck [3], who observed that walking ability
reached a plateau by the age of 7 years. It is also in
agreement with longitudinal analysis of motor growth
curves showing peak motor performance at 6 to 7 years of
age [1, 13, 33]. We found, however, that the proportion of
children walking independently on uneven surfaces (FMS
6) was incrementally higher in each age group up to
18 years. Hanna et al. [13] reported increased gross motor
function (ie, capability) in adolescents at GMFCS I–II.
Palisano et al. [25] described improved walking perfor-
mance outdoors in adolescents at GMFCS II. Ability to
walk on uneven surfaces is important to achieve indepen-
dent mobility and improve accessibility in the community,
where different surfaces, inclines, curbs, and stairs are
more common [28]. This has clinical relevance because
older children and adolescents do more activities outside
the home with friends than younger children [26]. Those
at GMFCS I do more activities outside than those at
Levels II–III [26]. This may be the result of their unre-
stricted walking performance. Hanna et al. [13] reported a
decline in gross motor function in children at GMFCS III–V
from 8 years of age. Strauss et al. [35] found a decline in
walking ability from 20 years and Jahnsen et al. [17]
observed a reduction in gross motor function in adults at
GMFCS II–III, mostly as a result of lack of balance, fear of
falling, pain, and exhaustion. Raja et al. [31] showed an
increasing energy cost with each level of decreasing FMS
score and doubled when walking outdoors on uneven sur-
faces compared with even surfaces indoors. This may
explain why 59% of the children at GMFCS Level III
walked 5 m at home, whereas only 16% walked 500 m in
the community. In the present study we found no increased
use of walking aids or wheelchair with age as reported for
adults. In the CPUP program, the number of children who
develop severe contractures or hip dislocation has been
reduced [11, 12]. This improvement could result in a
diminished or delayed decrease in walking performance. In
general, younger children with CP get more intense treat-
ment and followup by their physical therapists than
adolescents and adults. A continuous treatment and training
to increase oxygen uptake, improve balance and strength,
maintain joint ROM, and reduce pain throughout adoles-
cence may further improve walking performance or
prevent a reduction in walking ability. The CPUP health-
care program continues to monitor the adolescents with CP
as they grow into adults.
This study shows the most frequent mobility method at
different distances and environments in an unselected total
population of children with CP. We found a variation in
walking performance related to CP subtype and a high
correlation between the FMS and the GMFCS. The overall
Volume 470, Number 5, May 2012 Walking Performance in Children With CP 1291
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the proportion of children walking independently on
uneven surfaces was incrementally higher in each age
group up to 18 years. The improved performance on
uneven surfaces is important for achieving independent
walking and improves accessibility in the community.
Continuous followup and treatment to improve and main-
tain walking performance is important both in children and
adolescents with CP.
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